Skip to main content

Eldridge George A's Form 4 filing

Jade Biosciences, Inc. (JBIO) · filed Dec 13, 2022

Accession no.
0001415889-22-012508
Filed
Dec 13, 2022
Trade date
Dec 9-12, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $397.2K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Eldridge George ACIK 0001413006Officer (SEE REMARKS)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 9, 2022Common StockMOption exerciseAcquired+3,969$2.14+$8,493.665,929Direct
Dec 9, 2022Common StockSSaleDisposed−3,386$24.23−$82,042.782,543Direct
Dec 9, 2022Common StockSSaleDisposed−583$25.23−$14,709.091,960Direct
Dec 12, 2022Common StockMOption exerciseAcquired+10,000$2.14+$21,40011,960Direct
Dec 12, 2022Common StockSSaleDisposed−10,000$30.04−$300,4001,960Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 9, 2022Common StockMOption exerciseDisposed−3,969$0.00$036,757Direct
Dec 12, 2022Common StockMOption exerciseDisposed−7,094$0.00$029,663Direct
Dec 12, 2022Common StockMOption exerciseDisposed−2,906$0.00$079,863Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)